LRI Investments LLC Sells 595 Shares of CVS Health Corporation $CVS

LRI Investments LLC lessened its stake in CVS Health Corporation (NYSE:CVS) by 4.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,556 shares of the pharmacy operator’s stock after selling 595 shares during the period. LRI Investments LLC’s holdings in CVS Health were worth $935,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Bell Investment Advisors Inc grew its position in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 248 shares during the period. Roxbury Financial LLC boosted its stake in shares of CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 202 shares during the last quarter. ORG Partners LLC boosted its stake in shares of CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 377 shares during the last quarter. Saudi Central Bank purchased a new position in shares of CVS Health during the 1st quarter worth $34,000. Finally, Livelsberger Financial Advisory purchased a new position in shares of CVS Health during the 2nd quarter worth $35,000. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Cantor Fitzgerald reiterated an “overweight” rating and set a $78.00 price target on shares of CVS Health in a research note on Tuesday, August 26th. UBS Group upgraded shares of CVS Health from a “neutral” rating to a “buy” rating and lifted their target price for the company from $67.00 to $79.00 in a research note on Monday, August 18th. Sanford C. Bernstein lifted their target price on shares of CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a research note on Friday, September 5th. Morgan Stanley lifted their target price on shares of CVS Health from $80.00 to $82.00 and gave the company an “overweight” rating in a research note on Friday, August 1st. Finally, Bernstein Bank lowered their target price on shares of CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a research note on Wednesday, July 16th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $79.80.

Insider Buying and Selling

In related news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the transaction, the director directly owned 22,156 shares in the company, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.22% of the company’s stock.

CVS Health Stock Performance

CVS Health stock opened at $77.89 on Friday. The company’s 50-day moving average price is $72.28 and its 200-day moving average price is $67.67. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $79.20. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74. The company has a market cap of $98.79 billion, a PE ratio of 21.76, a price-to-earnings-growth ratio of 0.86 and a beta of 0.60.

CVS Health (NYSE:CVS) last posted its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping analysts’ consensus estimates of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. During the same period in the previous year, the firm posted $1.83 EPS. The business’s quarterly revenue was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.4%. The ex-dividend date is Thursday, October 23rd. CVS Health’s dividend payout ratio is presently 74.30%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.